Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves

Supinder S Bedi1, Peter A Walker, Shinil K Shah

  • 1From the Departments of Pediatric Surgery (S.S.B., P.A.W., S.K.S., F.J., C.P.T., P.S., R.A.H., H.X., C.S.C.), Surgery (P.A.W., S.K.S., R.A.H., H.X., C.S.C.), and Neurobiology and Anatomy (P.K.D.), University of Texas, Health Science Center at Houston, Houston; and Michael E DeBakey Institute for Comparative Cardiovascular Science and Biomedical Devices (S.K.S.), Texas A & M University, College Station, Texas; and Blood Systems Research Institute (S.P.); and Department of Laboratory Medicine (S.P.), University of California San Francisco, San Francisco, California.

Abstract

Related Concept Videos